| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Metabolic Research Unit (P.W., P.N., C.V., G.N.L., G.R.K.,
P.J.K.) University of California School of Medicine San
Francisco, California 94143
Department of Molecular and
Integrative Physiology (E.M., B.S.K.) University of Illinois
Urbana, Illinois 61801
KaroBio AB (S.N.)
Novum Huddinge, Sweden S-14157
Department of
Medical Nutrition and Biosciences (E.E., J.-A.G.) Karolinska
Institute Huddinge, Sweden S-14186
Estrogen receptors (ERs
and ß) enhance
transcription in response to estrogens by binding to estrogen response
elements (EREs) within target genes and utilizing transactivation
functions (AF-1 and AF-2) to recruit p160 coactivator proteins. The ERs
also enhance transcription in response to estrogens and antiestrogens
by modulating the activity of the AP-1 protein complex. Here, we
examine the role of AF-1 and AF-2 in ER action at AP-1 sites. Estrogen
responses at AP-1 sites require the integrity of the ER
AF-1 and
AF-2 activation surfaces and the complementary surfaces on the p160
coactivator GRIP1 (glucocorticoid receptor interacting protein 1), the
NID/AF-1 region, and NR boxes. Thus, estrogen-liganded ER
utilizes
the same protein-protein contacts to transactivate at EREs and AP-1
sites. In contrast, antiestrogen responses are strongly inhibited by
ER
AF-1 and weakly inhibited by AF-2. Indeed, ER
truncations that
lack AF-1 enhance AP-1 activity in the presence of antiestrogens, but
not estrogens. This phenotype resembles ERß, which naturally lacks
constitutive AF-1 activity. We conclude that the ERs enhance AP-1
responsive transcription by distinct mechanisms with different
requirements for ER transactivation functions. We suggest that
estrogen-liganded ER enhances AP-1 activity via interactions with p160s
and speculate that antiestrogen-liganded ER enhances AP-1 activity via
interactions with corepressors.
This article has been cited by other articles:
![]() |
F. Wu, I. Ivanov, R. Xu, and S. Safe Role of SP transcription factors in hormone-dependent modulation of genes in MCF-7 breast cancer cells: microarray and RNA interference studies J. Mol. Endocrinol., January 1, 2009; 42(1): 19 - 33. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Merot, F. Ferriere, L. Gailhouste, G. Huet, F. Percevault, C. Saligaut, and G. Flouriot Different Outcomes of Unliganded and Liganded Estrogen Receptor-{alpha} on Neurite Outgrowth in PC12 Cells Endocrinology, January 1, 2009; 150(1): 200 - 211. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Safe and K. Kim Non-classical genomic estrogen receptor (ER)/specificity protein and ER/activating protein-1 signaling pathways J. Mol. Endocrinol., November 1, 2008; 41(5): 263 - 275. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Tsutsumi, X. Zhang, K. Takata, K. Takahashi, R. H Karas, H. Kurachi, and M. E Mendelsohn Differential regulation of the inducible nitric oxide synthase gene by estrogen receptors 1 and 2 J. Endocrinol., November 1, 2008; 199(2): 267 - 273. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Sun, S. Zhang, D. Zhang, Y. Li, X. Zhao, Y. Luo, and Y. Guo Identification of Metastasis-Related Proteins and Their Clinical Relevance to Triple-Negative Human Breast Cancer Clin. Cancer Res., November 1, 2008; 14(21): 7050 - 7059. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Holmes, J. S. Song, X. S. Liu, M. Brown, and J. S. Carroll Nkx3-1 and LEF-1 Function as Transcriptional Inhibitors of Estrogen Receptor Activity Cancer Res., September 15, 2008; 68(18): 7380 - 7385. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Etgen Estrogens and Alzheimer's Disease: Is Cholesterol a Link? Endocrinology, September 1, 2008; 149(9): 4253 - 4255. [Full Text] [PDF] |
||||
![]() |
J. R. Hawse, M. Subramaniam, D. G. Monroe, A. H. Hemmingsen, J. N. Ingle, S. Khosla, M. J. Oursler, and T. C. Spelsberg Estrogen Receptor {beta} Isoform-Specific Induction of Transforming Growth Factor {beta}-Inducible Early Gene-1 in Human Osteoblast Cells: An Essential Role for the Activation Function 1 Domain Mol. Endocrinol., July 1, 2008; 22(7): 1579 - 1595. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Vagnerova, I. P. Koerner, and P. D. Hurn Gender and the Injured Brain Anesth. Analg., July 1, 2008; 107(1): 201 - 214. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Shen, I. P. Uray, Y. Li, Y. Zhang, J. Hill, X.-C. Xu, M. R. Young, E. J. Gunther, S. G. Hilsenbeck, N. H. Colburn, et al. Targeting the Activator Protein 1 Transcription Factor for the Prevention of Estrogen Receptor-Negative Mammary Tumors Cancer Prevention Research, June 1, 2008; 1(1): 45 - 55. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. J. Higgins, S. Liu, M. Abdelrahim, K. Vanderlaag, X. Liu, W. Porter, R. Metz, and S. Safe Vascular Endothelial Growth Factor Receptor-2 Expression Is Down-Regulated by 17{beta}-Estradiol in MCF-7 Breast Cancer Cells by Estrogen Receptor {alpha}/Sp Proteins Mol. Endocrinol., February 1, 2008; 22(2): 388 - 402. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Mrkonjic, S. Raptis, R. C. Green, N. Monga, D. Daftary, E. Dicks, H.B. Younghusband, P. S. Parfrey, S. S. Gallinger, J. R. McLaughlin, et al. MSH2 118T>C and MSH6 159C>T promoter polymorphisms and the risk of colorectal cancer Carcinogenesis, December 1, 2007; 28(12): 2575 - 2580. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Ansari and J. Gandy Determining the Transrepression Activity of Xenoestrogen on Nuclear Factor-{kappa}B in Cos-1 Cells by Estrogen Receptor-{alpha} International Journal of Toxicology, September 1, 2007; 26(5): 441 - 449. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Heldring, A. Pike, S. Andersson, J. Matthews, G. Cheng, J. Hartman, M. Tujague, A. Strom, E. Treuter, M. Warner, et al. Estrogen Receptors: How Do They Signal and What Are Their Targets Physiol Rev, July 1, 2007; 87(3): 905 - 931. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. M. Jaber, T. Gao, L. Huang, S. Karmakar, and C. L. Smith The Pure Estrogen Receptor Antagonist ICI 182,780 Promotes a Novel Interaction of Estrogen Receptor-{alpha} with the 3',5'-Cyclic Adenosine Monophosphate Response Element-Binding Protein-Binding Protein/p300 Coactivators Mol. Endocrinol., November 1, 2006; 20(11): 2695 - 2710. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Dong, C.-H. Tsai-Morris, and M. L. Dufau A Novel Estradiol/Estrogen Receptor {alpha}-dependent Transcriptional Mechanism Controls Expression of the Human Prolactin Receptor J. Biol. Chem., July 7, 2006; 281(27): 18825 - 18836. [Abstract] [Full Text] [PDF] |
||||
![]() |
M L Panno, L Mauro, S Marsico, D Bellizzi, P Rizza, C Morelli, M Salerno, F Giordano, and S Ando' Evidence that the mouse insulin receptor substrate-1 belongs to the gene family on which the promoter is activated by estrogen receptor {alpha} through its interaction with Sp1 J. Mol. Endocrinol., February 1, 2006; 36(1): 91 - 105. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Yager and N. E. Davidson Estrogen Carcinogenesis in Breast Cancer N. Engl. J. Med., January 19, 2006; 354(3): 270 - 282. [Full Text] [PDF] |
||||
![]() |
L-A Martin, S Pancholi, C M W Chan, I Farmer, C Kimberley, M Dowsett, and S R D Johnston The anti-oestrogen ICI 182,780, but not tamoxifen, inhibits the growth of MCF-7 breast cancer cells refractory to long-term oestrogen deprivation through down-regulation of oestrogen receptor and IGF signalling Endocr. Relat. Cancer, December 1, 2005; 12(4): 1017 - 1036. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Matthews, B. Wihlen, J. Thomsen, and J.-A. Gustafsson Aryl Hydrocarbon Receptor-Mediated Transcription: Ligand-Dependent Recruitment of Estrogen Receptor {alpha} to 2,3,7,8-Tetrachlorodibenzo- p-Dioxin-Responsive Promoters Mol. Cell. Biol., July 1, 2005; 25(13): 5317 - 5328. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Gutzman, S. E. Nikolai, D. E. Rugowski, J. J. Watters, and L. A. Schuler Prolactin and Estrogen Enhance the Activity of Activating Protein 1 in Breast Cancer Cells: Role of Extracellularly Regulated Kinase 1/2-Mediated Signals to c-fos Mol. Endocrinol., July 1, 2005; 19(7): 1765 - 1778. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. I. Boulware, J. P. Weick, B. R. Becklund, S. P. Kuo, R. D. Groth, and P. G. Mermelstein Estradiol Activates Group I and II Metabotropic Glutamate Receptor Signaling, Leading to Opposing Influences on cAMP Response Element-Binding Protein J. Neurosci., May 18, 2005; 25(20): 5066 - 5078. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kim, R. Barhoumi, R. Burghardt, and S. Safe Analysis of Estrogen Receptor {alpha}-Sp1 Interactions in Breast Cancer Cells by Fluorescence Resonance Energy Transfer Mol. Endocrinol., April 1, 2005; 19(4): 843 - 854. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Bjornstrom and M. Sjoberg Mechanisms of Estrogen Receptor Signaling: Convergence of Genomic and Nongenomic Actions on Target Genes Mol. Endocrinol., April 1, 2005; 19(4): 833 - 842. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. G. DeNardo, H.-T. Kim, S. Hilsenbeck, V. Cuba, A. Tsimelzon, and P. H. Brown Global Gene Expression Analysis of Estrogen Receptor Transcription Factor Cross Talk in Breast Cancer: Identification of Estrogen-Induced/Activator Protein-1-Dependent Genes Mol. Endocrinol., February 1, 2005; 19(2): 362 - 378. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. R. Pak, W. C. J. Chung, T. D. Lund, L. R. Hinds, C. M. Clay, and R. J. Handa The Androgen Metabolite, 5{alpha}-Androstane-3{beta}, 17{beta}-Diol, Is a Potent Modulator of Estrogen Receptor-{beta}1-Mediated Gene Transcription in Neuronal Cells Endocrinology, January 1, 2005; 146(1): 147 - 155. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. H. Herynk and S. A. W. Fuqua Estrogen Receptor Mutations in Human Disease Endocr. Rev., December 1, 2004; 25(6): 869 - 898. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. E. Baker, V. M. Brautigam, and J. J. Watters Estrogen Modulates Microglial Inflammatory Mediator Production via Interactions with Estrogen Receptor {beta} Endocrinology, November 1, 2004; 145(11): 5021 - 5032. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. E. Damdimopoulos, A. Miranda-Vizuete, E. Treuter, J.-A. Gustafsson, and G. Spyrou An Alternative Splicing Variant of the Selenoprotein Thioredoxin Reductase Is a Modulator of Estrogen Signaling J. Biol. Chem., September 10, 2004; 279(37): 38721 - 38729. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. H. Smith, S. R. Coats, H. Qin, M. S. Petrie, J. W. Covington, M. Su, M. Eren, and D. E. Vaughan Differential and Opposing Regulation of PAI-1 Promoter Activity by Estrogen Receptor {alpha} and Estrogen Receptor {beta} in Endothelial Cells Circ. Res., August 6, 2004; 95(3): 269 - 275. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. O'Lone, M. C. Frith, E. K. Karlsson, and U. Hansen Genomic Targets of Nuclear Estrogen Receptors Mol. Endocrinol., August 1, 2004; 18(8): 1859 - 1875. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Ni, Y. Hou, B. R. King, X. Tang, M. A. Read, R. Smith, and R. C. Nicholson Estrogen Receptor-Mediated Down-Regulation of Corticotropin-Releasing Hormone Gene Expression Is Dependent on a Cyclic Adenosine 3',5'-Monophosphate Regulatory Element in Human Placental Syncytiotrophoblast Cells J. Clin. Endocrinol. Metab., May 1, 2004; 89(5): 2312 - 2318. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Heldring, M. Nilsson, B. Buehrer, E. Treuter, and J.-A. Gustafsson Identification of Tamoxifen-Induced Coregulator Interaction Surfaces within the Ligand-Binding Domain of Estrogen Receptors Mol. Cell. Biol., April 15, 2004; 24(8): 3445 - 3459. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Ismail, C. V. Nguyen, A. Ahene, J. C. Fleet, M. R. Uskokovic, and S. Peleg Effect of Cellular Environment on the Selective Activation of the Vitamin D Receptor by 1{alpha},25-Dihydroxyvitamin D3 and Its Analog 1{alpha}-Fluoro-16-Ene-20-Epi-23-Ene-26,27-Bishomo-25-Hydroxyvitamin D3 (Ro-26-9228) Mol. Endocrinol., April 1, 2004; 18(4): 874 - 887. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Cheng, Z. Weihua, M. Warner, and J.-A. Gustafsson Inaugural Article: Estrogen receptors ER{alpha} and ER{beta} in proliferation in the rodent mammary gland PNAS, March 16, 2004; 101(11): 3739 - 3746. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. N. Petz, Y. S. Ziegler, J. R. Schultz, and A. M. Nardulli Fos and Jun Inhibit Estrogen-Induced Transcription of the Human Progesterone Receptor Gene through an Activator Protein-1 Site Mol. Endocrinol., March 1, 2004; 18(3): 521 - 532. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. N. Dieudonne, M. C. Leneveu, Y. Giudicelli, and R. Pecquery Evidence for functional estrogen receptors {alpha} and {beta} in human adipose cells: regional specificities and regulation by estrogens Am J Physiol Cell Physiol, March 1, 2004; 286(3): C655 - C661. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. D. Toran-Allerand Minireview: A Plethora of Estrogen Receptors in the Brain: Where Will It End? Endocrinology, March 1, 2004; 145(3): 1069 - 1074. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Frasor, F. Stossi, J. M. Danes, B. Komm, C. R. Lyttle, and B. S. Katzenellenbogen Selective Estrogen Receptor Modulators: Discrimination of Agonistic versus Antagonistic Activities by Gene Expression Profiling in Breast Cancer Cells Cancer Res., February 15, 2004; 64(4): 1522 - 1533. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Zhao, A. Koide, J. Abrams, S. Deighton-Collins, A. Martinez, J. A. Schwartz, S. Koide, and D. F. Skafar Mutation of Leu-536 in Human Estrogen Receptor-{alpha} Alters the Coupling between Ligand Binding, Transcription Activation, and Receptor Conformation J. Biol. Chem., July 11, 2003; 278(29): 27278 - 27286. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M. M. Kelley, B. G. Rowan, and M. Ratnam Modulation of the Folate Receptor {alpha} Gene by the Estrogen Receptor: Mechanism and Implications in Tumor Targeting Cancer Res., June 1, 2003; 63(11): 2820 - 2828. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kim, N. Thu, B. Saville, and S. Safe Domains of Estrogen Receptor {alpha} (ER{alpha}) Required for ER{alpha}/Sp1-Mediated Activation of GC-Rich Promoters by Estrogens and Antiestrogens in Breast Cancer Cells Mol. Endocrinol., May 1, 2003; 17(5): 804 - 817. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Webb, P. Nguyen, and P. J. Kushner Differential SERM Effects on Corepressor Binding Dictate ERalpha Activity in Vivo J. Biol. Chem., February 21, 2003; 278(9): 6912 - 6920. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Khosravi and P. C. K. Leung Differential Regulation of Gonadotropin-Releasing Hormone (GnRH)I and GnRHII Messenger Ribonucleic Acid by Gonadal Steroids in Human Granulosa Luteal Cells J. Clin. Endocrinol. Metab., February 1, 2003; 88(2): 663 - 672. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Teyssier, K. Belguise, F. Galtier, V. Cavailles, and D. Chalbos Receptor-Interacting Protein 140 Binds c-Jun and Inhibits Estradiol-Induced Activator Protein-1 Activity by Reversing Glucocorticoid Receptor-Interacting Protein 1 Effect Mol. Endocrinol., February 1, 2003; 17(2): 287 - 299. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Zhou, G. Turgeman, S. E. Harris, D. C. Leitman, B. S. Komm, P. V. N. Bodine, and D. Gazit Estrogens Activate Bone Morphogenetic Protein-2 Gene Transcription in Mouse Mesenchymal Stem Cells Mol. Endocrinol., January 1, 2003; 17(1): 56 - 66. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Bjornstrom and M. Sjoberg Mutations in the Estrogen Receptor DNA-binding Domain Discriminate between the Classical Mechanism of Action and Cross-talk with Stat5b and Activating Protein 1 (AP-1) J. Biol. Chem., December 6, 2002; 277(50): 48479 - 48483. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. N. Petz, Y. S. Ziegler, M. A. Loven, and A. M. Nardulli Estrogen Receptor {alpha} and Activating Protein-1 Mediate Estrogen Responsiveness of the Progesterone Receptor Gene in MCF-7 Breast Cancer Cells Endocrinology, December 1, 2002; 143(12): 4583 - 4591. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Jakacka, M. Ito, F. Martinson, T. Ishikawa, E. J. Lee, and J. L. Jameson An Estrogen Receptor (ER){alpha} Deoxyribonucleic Acid-Binding Domain Knock-In Mutation Provides Evidence for Nonclassical ER Pathway Signaling in Vivo Mol. Endocrinol., October 1, 2002; 16(10): 2188 - 2201. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Molero, M. Garcia-Duran, J. Diaz-Recasens, L. Rico, S. Casado, and A. Lopez-Farre Expression of estrogen receptor subtypes and neuronal nitric oxide synthase in neutrophils from women and men: Regulation by estrogen Cardiovasc Res, October 1, 2002; 56(1): 43 - 51. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Marino, F. Acconcia, F. Bresciani, A. Weisz, and A. Trentalance Distinct Nongenomic Signal Transduction Pathways Controlled by 17beta -Estradiol Regulate DNA Synthesis and Cyclin D1 Gene Transcription in HepG2 Cells Mol. Biol. Cell, October 1, 2002; 13(10): 3720 - 3729. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Qin, T. Nguyen, J. Stewart, I. Samudio, R. Burghardt, and S. Safe Estrogen Up-Regulation of p53 Gene Expression in MCF-7 Breast Cancer Cells Is Mediated by Calmodulin Kinase IV-Dependent Activation of a Nuclear Factor {kappa}B/CCAAT-Binding Transcription Factor-1 Complex Mol. Endocrinol., August 1, 2002; 16(8): 1793 - 1809. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-M. Liu, C. Albanese, C. M. Anderson, K. Hilty, P. Webb, R. M. Uht, R. H. Price Jr., R. G. Pestell, and P. J. Kushner Opposing Action of Estrogen Receptors alpha and beta on Cyclin D1 Gene Expression J. Biol. Chem., June 28, 2002; 277(27): 24353 - 24360. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. V. Karamouzis, V. G. Gorgoulis, and A. G. Papavassiliou Transcription Factors and Neoplasia: Vistas in Novel Drug Design Clin. Cancer Res., May 1, 2002; 8(5): 949 - 961. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. L. Gadd, G. Hobbs, and M. R. Miller Acetaminophen-Induced Proliferation of Estrogen-Responsive Breast Cancer Cells Is Associated with Increases in c-myc RNA Expression and NF-{kappa}B Activity Toxicol. Sci., April 1, 2002; 66(2): 233 - 243. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. T. Solum and R. J. Handa Estrogen Regulates the Development of Brain-Derived Neurotrophic Factor mRNA and Protein in the Rat Hippocampus J. Neurosci., April 1, 2002; 22(7): 2650 - 2659. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kato, S. Horiuchi, A. Takahashi, Y. Ueoka, T. Arima, T. Matsuda, H. Kato, J.-i. Nishida, Y. Nakabeppu, and N. Wake Contribution of Estrogen Receptor alpha to Oncogenic K-Ras-mediated NIH3T3 Cell Transformation and Its Implication for Escape from Senescence by Modulating the p53 Pathway J. Biol. Chem., March 22, 2002; 277(13): 11217 - 11224. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. X.-D. Song, R. A. McPherson, L. Adam, Y. Bao, M. Shupnik, R. Kumar, and R. J. Santen Linkage of Rapid Estrogen Action to MAPK Activation by ER{alpha}-Shc Association and Shc Pathway Activation Mol. Endocrinol., January 1, 2002; 16(1): 116 - 127. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. El-Tanani, D. G. Fernig, R. Barraclough, C. Green, and P. Rudland Differential Modulation of Transcriptional Activity of Estrogen Receptors by Direct Protein-Protein Interactions with the T Cell Factor Family of Transcription Factors J. Biol. Chem., November 2, 2001; 276(45): 41675 - 41682. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Krieg, A. J. Krieg, and D. J. Shapiro A Unique Downstream Estrogen Responsive Unit Mediates Estrogen Induction of Proteinase Inhibitor-9, a Cellular Inhibitor of IL-1{beta}- Converting Enzyme (Caspase 1) Mol. Endocrinol., November 1, 2001; 15(11): 1971 - 1982. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Nagel, J. L. Hagelbarger, and D. P. McDonnell Development of an ER Action Indicator Mouse for the Study of Estrogens, Selective ER Modulators (SERMs), and Xenobiotics Endocrinology, November 1, 2001; 142(11): 4721 - 4728. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. C. Jordan, S. Gapstur, and M. Morrow Selective Estrogen Receptor Modulation and Reduction in Risk of Breast Cancer, Osteoporosis, and Coronary Heart Disease J Natl Cancer Inst, October 3, 2001; 93(19): 1449 - 1457. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Nilsson, S. Makela, E. Treuter, M. Tujague, J. Thomsen, G. Andersson, E. Enmark, K. Pettersson, M. Warner, and J.-A. Gustafsson Mechanisms of Estrogen Action Physiol Rev, October 1, 2001; 81(4): 1535 - 1565. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Chisamore, Y. Ahmed, D. J. Bentrem, V. C. Jordan, and D. A. Tonetti Novel Antitumor Effect of Estradiol in Athymic Mice Injected with a T47D Breast Cancer Cell Line Overexpressing Protein Kinase C{alpha} Clin. Cancer Res., October 1, 2001; 7(10): 3156 - 3165. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Lazennec, D. Bresson, A. Lucas, C. Chauveau, and F. Vignon ER{beta} Inhibits Proliferation and Invasion of Breast Cancer Cells Endocrinology, September 1, 2001; 142(9): 4120 - 4130. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Klinge Estrogen receptor interaction with estrogen response elements Nucleic Acids Res., July 15, 2001; 29(14): 2905 - 2919. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Yu, V. Hebbar, D. W. Kim, S. Mandlekar, J. M. Pezzuto, and A.-N. T. Kong Resveratrol Inhibits Phorbol Ester and UV-Induced Activator Protein 1 Activation by Interfering with Mitogen-Activated Protein Kinase Pathways Mol. Pharmacol., July 1, 2001; 60(1): 217 - 224. [Abstract] [Full Text] |
||||
![]() |
R. H. Price Jr., C. A. Butler, P. Webb, R. Uht, P. Kushner, and R. J. Handa A Splice Variant of Estrogen Receptor {beta} Missing Exon 3 Displays Altered Subnuclear Localization and Capacity for Transcriptional Activation Endocrinology, May 1, 2001; 142(5): 2039 - 2049. [Abstract] [Full Text] |
||||
![]() |
R. D. Brinton Cellular and Molecular Mechanisms of Estrogen Regulation of Memory Function and Neuroprotection Against Alzheimer's Disease: Recent Insights and Remaining Challenges Learn. Mem., May 1, 2001; 8(3): 121 - 133. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Vegeto, C. Bonincontro, G. Pollio, A. Sala, S. Viappiani, F. Nardi, A. Brusadelli, B. Viviani, P. Ciana, and A. Maggi Estrogen Prevents the Lipopolysaccharide-Induced Inflammatory Response in Microglia J. Neurosci., March 15, 2001; 21(6): 1809 - 1818. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Samudio, C. Vyhlidal, F. Wang, M. Stoner, I. Chen, M. Kladde, R. Barhoumi, R. Burghardt, and S. Safe Transcriptional Activation of Deoxyribonucleic Acid Polymerase {{alpha}} Gene Expression in MCF-7 Cells by 17{{beta}}-Estradiol Endocrinology, March 1, 2001; 142(3): 1000 - 1008. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Quaedackers, C. E. Van Den Brink, S. Wissink, R. H. M. M. Schreurs, J.-A. Gustafsson, P. T. Van Der Saag, and B. Van Der Burg 4-Hydroxytamoxifen Trans-Represses Nuclear Factor-{{kappa}}B Activity in Human Osteoblastic U2-OS Cells through Estrogen Receptor (ER){{alpha}}, and Not through ER{{beta}} Endocrinology, March 1, 2001; 142(3): 1156 - 1166. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Lu and V. Giguere Requirement of Ras-Dependent Pathways for Activation of the Transforming Growth Factor {beta}3 Promoter by Estradiol Endocrinology, February 1, 2001; 142(2): 751 - 759. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Feng, P. Webb, P. Nguyen, X. Liu, J. Li, M. Karin, and P. J. Kushner Potentiation of Estrogen Receptor Activation Function 1 (AF-1) by Src/JNK through a Serine 118-Independent Pathway Mol. Endocrinol., January 1, 2001; 15(1): 32 - 45. [Abstract] [Full Text] |
||||
![]() |
R. Schiff, P. Reddy, M. Ahotupa, E. Coronado-Heinsohn, M. Grim, S. G. Hilsenbeck, R. Lawrence, S. Deneke, R. Herrera, G. C. Chamness, et al. Oxidative Stress and AP-1 Activity in Tamoxifen-Resistant Breast Tumors In Vivo J Natl Cancer Inst, December 6, 2000; 92(23): 1926 - 1934. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Klotz, S. C. Hewitt, K. S. Korach, and R. P. Diaugustine Activation of a Uterine Insulin-Like Growth Factor I Signaling Pathway by Clinical and Environmental Estrogens: Requirement of Estrogen Receptor-{alpha} Endocrinology, September 1, 2000; 141(9): 3430 - 3439. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. P. Bocchinfuso, J. K. Lindzey, S. C. Hewitt, J. A. Clark, P. H. Myers, R. Cooper, and K. S. Korach Induction of Mammary Gland Development in Estrogen Receptor-{alpha} Knockout Mice Endocrinology, August 1, 2000; 141(8): 2982 - 2994. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. B. Dickson and G. M. Stancel Chapter 8: Estrogen Receptor-Mediated Processes in Normal and Cancer Cells J Natl Cancer Inst Monographs, July 1, 2000; 2000(27): 135 - 145. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Yao, E.-S. Lee, D. J. Bentrem, G. England, J. I. M. Schafer, R. M. O'Regan, and V. C. Jordan Antitumor Action of Physiological Estradiol on Tamoxifen-stimulated Breast Tumors Grown in Athymic Mice Clin. Cancer Res., May 1, 2000; 6(5): 2028 - 2036. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. J. Scheidegger, B. Cenni, D. Picard, and P. Delafontaine Estradiol Decreases IGF-1 and IGF-1 Receptor Expression in Rat Aortic Smooth Muscle Cells. MECHANISMS FOR ITS ATHEROPROTECTIVE EFFECTS J. Biol. Chem., December 1, 2000; 275(49): 38921 - 38928. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. V. Weatherman and T. S. Scanlan Unique Protein Determinants of the Subtype-selective Ligand Responses of the Estrogen Receptors (ERalpha and ERbeta ) at AP-1 Sites J. Biol. Chem., February 2, 2001; 276(6): 3827 - 3832. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Webb, P. Nguyen, C. Valentine, R. V. Weatherman, T. S. Scanlan, and P. J. Kushner An Antiestrogen-responsive Estrogen Receptor-alpha Mutant (D351Y) Shows Weak AF-2 Activity in the Presence of Tamoxifen J. Biol. Chem., November 22, 2000; 275(48): 37552 - 37558. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Jakacka, M. Ito, J. Weiss, P.-Y. Chien, B. D. Gehm, and J. L. Jameson Estrogen Receptor Binding to DNA Is Not Required for Its Activity through the Nonclassical AP1 Pathway J. Biol. Chem., April 20, 2001; 276(17): 13615 - 13621. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. An, C. Tzagarakis-Foster, T. C. Scharschmidt, N. Lomri, and D. C. Leitman Estrogen Receptor beta -Selective Transcriptional Activity and Recruitment of Coregulators by Phytoestrogens J. Biol. Chem., May 18, 2001; 276(21): 17808 - 17814. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Teyssier, K. Belguise, F. Galtier, and D. Chalbos Characterization of the Physical Interaction between Estrogen Receptor alpha and JUN Proteins J. Biol. Chem., September 21, 2001; 276(39): 36361 - 36369. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Walters, M. Dutertre, and C. L. Smith SKF-82958 Is a Subtype-selective Estrogen Receptor-alpha (ERalpha ) Agonist That Induces Functional Interactions between ERalpha and AP-1 J. Biol. Chem., January 11, 2002; 277(3): 1669 - 1679. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kahlert, S. Nuedling, M. van Eickels, H. Vetter, R. Meyer, and C. Grohe Estrogen Receptor alpha Rapidly Activates the IGF-1 Receptor Pathway J. Biol. Chem., June 9, 2000; 275(24): 18447 - 18453. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |